Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes

Immunotherapies harnessing T cell immunity have shown remarkable clinical success for the management of cancer. However, only a proportion of patients benefit from these treatments. The presence of type I interferon (IFN) within the tumor microenvironment is critical for driving effective tumor-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Buzzai, Anthony C., Wagner, Teagan, Audsley, Katherine M., Newnes, Hannah V., Barrett, Lucy W., Barnes, Samantha, Wylie, Ben C., Stone, Shane, McDonnell, Alison, Fear, Vanessa S., Foley, Bree, Waithman, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145903/
https://www.ncbi.nlm.nih.gov/pubmed/32308653
http://dx.doi.org/10.3389/fimmu.2020.00542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145903/
https://www.ncbi.nlm.nih.gov/pubmed/32308653
http://dx.doi.org/10.3389/fimmu.2020.00542

Ejemplares similares